Progressive Corp vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Progressive Corp trades at $218.9 (market cap $124.28B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Progressive Corp is far larger — about 4.9× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Progressive Corp for 81 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| PGR | RPRX | |
|---|---|---|
Market Cap | $124.28B | $25.27B |
Volume | 2,551,191 | 3,671,183 |
Sector | Financials | Health |
52-Week High | $242.16 | $63.96 |
52-Week Low | $190.40 | $35.44 |
Typical Hold Time | 81 Days | 0 Days |
Enterprise Value | $132.48B | $32.50B |
Dividend Yield | 0.19% | 1.66% |
Signals from Pluang's Aura AI — not financial advice
PGR trades at $218.73, up 3.15% today, with a bullish technical signal from moving averages and strong fundamentals including a 12.85% net income margin and 34.94% ROE. Revenue grew from $49.6B in 2022 to $87.6B in 2025, with net income surging to $11.3B. The company recently announced a $0.10 dividend payable in October 2026, and Q2 2026 earnings beat expectations.
The outlook is positive given robust earnings growth and analyst consensus price target of $222.23, though risks include intensifying competition in personal auto insurance and potential market volatility. Institutional interest remains strong with recent position increases by funds like QRG Capital Management.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →